Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a variety of symptoms, including irregular menstrual cycles, infertility, obesity, hirsutism, acne, and insulin resistance. PCOS is a complex disorder, and its pathogenesis remains largely unknown. Despite its prevalence, PCOS is often underdiagnosed or misdiagnosed due to the lack of a clear diagnostic criteria. This article aims to provide an overview of PCOS and its management, in order to help physicians better recognize and treat the disorder.
PCOS is a heterogeneous disorder with variable presentations. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation is defined as the absence of ovulation, and is the most common symptom of PCOS. Hyperandrogenism is the presence of elevated androgens, such as testosterone, in the blood. Polycystic ovarian morphology is the presence of multiple small cysts in the ovaries, which can be seen on ultrasound.
The diagnosis of PCOS is based on the presence of two of the three criteria: anovulation, hyperandrogenism, and polycystic ovarian morphology. Anovulation can be diagnosed by a history of irregular menstrual cycles, or by monitoring for ovulation with basal body temperature or urinary luteinizing hormone (LH) tests. Hyperandrogenism can be diagnosed by measuring serum testosterone and other androgens. Polycystic ovarian morphology can be diagnosed by transvaginal ultrasound.
PCOS is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. Infertility is the most common complication of PCOS, and is caused by the lack of ovulation. Obesity is also common in PCOS, and is thought to be due to insulin resistance. Hirsutism, acne, and insulin resistance can also be caused by the elevated androgens associated with PCOS.
The management of PCOS depends on the patient's individual presentation and goals. For those with fertility issues, ovulation induction with drugs such as clomiphene citrate or gonadotropins may be recommended. For those with hirsutism, acne, or obesity, lifestyle modifications such as diet and exercise as well as medications such as metformin or spironolactone may be recommended.
PCOS is a complex disorder that affects many women of reproductive age. It is characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology, and is associated with a number of complications, including infertility, obesity, hirsutism, acne, and insulin resistance. The diagnosis of PCOS is based on the presence of two of the three criteria, and the management of PCOS depends on the patient's individual presentation and goals. With a better understanding of PCOS and its management, physicians can help women better recognize and treat the disorder.
1.
Study finds 81% of cancer cures touted by TikTok videos are fake
2.
Telemedicine Not Reaching Rural Psychiatric Patients
3.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
4.
A study outlines the need for policies that enhance cancer patients' autonomy and information.
5.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
1.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
2.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
3.
Understanding Mantle Cell Lymphoma Prognosis.
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation